 |
 |

Neurologic Complications of Gaucher's Disease, Type 3
Robert N. Nishimura, MD;
John A. Barranger, MD, PhD
Arch Neurol. 1980;37(2):92-93.
Abstract
We discuss the clinical features of two patients with type 3 Gaucher's disease. Glucocerebroside levels in liver biopsy specimens were measured in both patients and the findings are discussed in regard to the pathogenesis of the disease.
Author Affiliations
From the Developmental and Metabolic Neurology Branch, National Institutes of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Md.
Footnotes
Accepted for publication Feb 20, 1979.
Reprint requests to Developmental and Metabolic Neurology Branch, National Institutes of Neurological Disorders and Stroke, National Institutes of Health, Bldg 10, Room 4N-248, Bethesda, MD 20014 (Dr Nishimura).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Clinical Heterogeneity Among Patients With Gaucher's Disease
Sidransky and Ginns
JAMA 1993;269:1154-1157.
ABSTRACT
Diagnosis of Rare Dementia Syndromes: An Algorithmic Approach
Reichman and Cummings
J Geriatr Psychiatry Neurol 1990;3:73-84.
ABSTRACT
|